BioCryst Partners with Er-Kim Pharmaceuticals for Commercialization of ORLADEYO®

BioCryst Pharmaceuticals, Inc. has joined forces with Er-Kim Pharmaceuticals to bring ORLADEYO® (berotralstat) to the Turkish market, in line with their mission to provide access to the medication for patients worldwide. Er-Kim's expertise in delivering innovative therapies to patients with unmet medical needs makes them an ideal partner for BioCryst. ORLADEYO is a groundbreaking oral therapy sp..